These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11516865)

  • 1. Analysis of toxicity of Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group study.
    Poulsen M; Rischin D; Walpole E; Harvey J; Macintosh J; Ainslie J; Hamilton C; Keller J; Tripcony L
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):156-63. PubMed ID: 11516865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study--TROG 96:07.
    Poulsen M; Rischin D; Walpole E; Harvey J; Mackintosh J; Ainslie J; Hamilton C; Keller J; Tripcony L;
    J Clin Oncol; 2003 Dec; 21(23):4371-6. PubMed ID: 14645427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weekly carboplatin reduces toxicity during synchronous chemoradiotherapy for Merkel cell carcinoma of skin.
    Poulsen M; Walpole E; Harvey J; Dickie G; O'Brien P; Keller J; Tripcony L; Rischin D
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1070-4. PubMed ID: 18707820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin?
    Poulsen MG; Rischin D; Porter I; Walpole E; Harvey J; Hamilton C; Keller J; Tripcony L
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):114-9. PubMed ID: 16125873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I and pharmacologic study of sequential topotecan-carboplatin-etoposide in patients with extensive stage small cell lung cancer.
    Miller AA; Al Omari A; Murry DJ; Case D
    Lung Cancer; 2006 Dec; 54(3):379-85. PubMed ID: 17049403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
    Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Merkel cell carcinoma: 27-year experience at the Peter MacCallum Cancer Centre.
    Hui AC; Stillie AL; Seel M; Ainslie J
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1430-5. PubMed ID: 20708847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further insights into the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma.
    Boyle F; Pendlebury S; Bell D
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):315-23. PubMed ID: 7836085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of paclitaxel, carboplatin, and increasing days of prolonged oral etoposide in ovarian, peritoneal, and tubal carcinoma: a gynecologic oncology group study.
    Rose PG; Rodriguez M; Waggoner S; Greer BE; Horowitz IR; Fowler JM; McGuire WP
    J Clin Oncol; 2000 Aug; 18(16):2957-62. PubMed ID: 10944128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for Merkel cell carcinoma with carboplatin and etoposide.
    Pectasides D; Moutzourides G; Dimitriadis M; Varthalitis J; Athanassiou A
    Am J Clin Oncol; 1995 Oct; 18(5):418-20. PubMed ID: 7572759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up.
    Zemanova M; Petruzelka L; Pazdro A; Kralova D; Smejkal M; Pazdrova G; Honova H
    Dis Esophagus; 2010 Feb; 23(2):160-7. PubMed ID: 19515190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of tirapazamine plus cisplatin/etoposide and concurrent thoracic radiotherapy in limited-stage small cell lung cancer (S0004): a Southwest Oncology Group study.
    Le QT; McCoy J; Williamson S; Ryu J; Gaspar LE; Edelman MJ; Dakhil SR; Sides SD; Crowley JJ; Gandara DR;
    Clin Cancer Res; 2004 Aug; 10(16):5418-24. PubMed ID: 15328179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of radiation therapy and chemotherapy in the treatment of Merkel cell carcinoma.
    Fenig E; Brenner B; Katz A; Rakovsky E; Hana MB; Sulkes A
    Cancer; 1997 Sep; 80(5):881-5. PubMed ID: 9307187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony-stimulating factor: a phase I study with apparent activity in non-small-cell lung cancer.
    Krigel RL; Palackdharry CS; Padavic K; Haas N; Kilpatrick D; Langer C; Comis R
    J Clin Oncol; 1994 Jun; 12(6):1251-8. PubMed ID: 8201386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
    Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
    Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-institutional phase I/II trial of paclitaxel, cisplatin, and etoposide with concurrent radiation for limited-stage small-cell lung carcinoma.
    Levitan N; Dowlati A; Shina D; Craffey M; Mackay W; DeVore R; Jett J; Remick SC; Chang A; Johnson D
    J Clin Oncol; 2000 Mar; 18(5):1102-9. PubMed ID: 10694563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy compliance in high-risk Merkel cell carcinoma treated with chemoradiotherapy.
    Gorayski P; Tripcony L; Poulsen M
    Australas J Dermatol; 2017 Feb; 58(1):35-41. PubMed ID: 26627052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent carboplatin, etoposide and thoracic radiation for poor-risk stage III non-small-cell lung carcinoma: a pilot study.
    Lau DH; Ryu JK; Gandara DR; Rosenthal SA
    Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):157-61. PubMed ID: 9212018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II trial of radiochemotherapy with daily carboplatin, after induction chemotherapy (carboplatin and etoposide), in locally advanced nonsmall-cell lung cancer: final analysis.
    Bardet E; Rivière A; Charloux A; Spaeth D; Ducoloné A; Le Groumellec A; Pellae-Cosset B; Henry-Amar M; Douillard JY
    Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):163-8. PubMed ID: 9212019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.